Atlas Trials

A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

Clinical trial NCT00739648 · COMPLETED

Trial details

NCT number
NCT00739648
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2008-10-01
Primary completion
2010-01-01
Enrollment
322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.